Pharma Mar (PHMMF) Short Interest Ratio & Short Volume $102.08 0.00 (0.00%) As of 03/18/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Pharma Mar Short Interest DataPharma Mar (PHMMF) has a short interest of 32,700 shares, representing 0.18% of the float (the number of shares available for trading by the public). This marks a 43.42% increase in short interest from the previous month. The short interest ratio (days to cover) is 327.0, indicating that it would take 327.0 days of the average trading volume of 1,075 shares to cover all short positions.Current Short Interest32,700 sharesPrevious Short Interest22,800 sharesChange Vs. Previous Month+43.42%Dollar Volume Sold Short$3.13 millionShort Interest Ratio327.0 Days to CoverLast Record DateFebruary 28, 2025Outstanding Shares18,010,000 sharesShort Percent of Float0.18%Today's Trading Volume0 sharesAverage Trading Volume1,075 sharesToday's Volume Vs. Average0% Short Selling Pharma Mar? Sign up to receive the latest short interest report for Pharma Mar and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPHMMF Short Interest Over TimePHMMF Days to Cover Over TimePHMMF Percentage of Float Shorted Over Time Remove Ads Pharma Mar Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/202532,700 shares $3.13 million +43.4%0.2%327 $95.79 2/15/202522,800 shares $2.18 million No Change0.1%228 $95.79 1/31/202522,800 shares $2.18 million -81.4%N/A4 $95.79 1/15/2025122,400 shares $9.92 million +436.8%N/A20.7 $81.07 12/31/202422,800 shares $1.85 million No ChangeN/A3.1 $81.07 12/15/202422,800 shares $1.85 million -0.9%N/A6.2 $81.07 11/30/202423,000 shares $1.73 million -13.2%N/A230 $75.00 11/15/202426,500 shares $1.99 million -0.4%N/A265 $75.00 10/31/202426,600 shares $2.00 million +116.3%N/A266 $75.00 10/15/202412,300 shares $875,760.00 -30.9%N/A123 $71.20 Get the Latest News and Ratings for PHMMF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharma Mar and its competitors with MarketBeat's FREE daily newsletter. 9/30/202417,800 shares $961,200.00 -47.8%N/A178 $54.00 9/15/202434,100 shares $1.56 million No ChangeN/A56.8 $45.85 8/31/202434,100 shares $1.53 million -0.3%N/A341 $44.90 8/15/202434,200 shares $1.17 million -14.3%N/A342 $34.26 7/31/202439,900 shares $1.37 million -16.2%N/A399 $34.26 7/15/202447,600 shares $1.63 million -7.8%N/A476 $34.26 6/30/202451,600 shares $1.82 million -9.0%N/A516 $35.23 6/15/202456,700 shares $1.77 million -11.7%N/A566.7 $31.15 5/31/202464,200 shares $2.00 million -3.2%N/A642 $31.15 5/15/202466,300 shares $2.07 million -6.2%N/A165.8 $31.15 4/30/202470,700 shares $1.90 million -1.0%N/A707 $26.85 4/15/202471,400 shares $1.92 million -0.3%N/A714 $26.85 3/31/202471,600 shares $2.10 million +3.8%N/A716 $29.29 3/15/202469,000 shares $2.10 million +4.6%N/A345 $30.38 2/29/202466,000 shares $2.30 million -3.7%N/A110 $34.90 2/15/202468,500 shares $3.02 million No ChangeN/A685 $44.13 1/15/202490,600 shares $3.92 million +38.7%N/A906 $43.28 12/31/202365,300 shares $3.02 million -2.3%N/A1087.6 $46.26 12/15/202366,800 shares $3.09 million +0.8%N/A133.6 $46.26 11/30/202366,300 shares $2.37 million No ChangeN/A663 $35.81 11/15/202366,300 shares $2.37 million -0.2%N/A165.8 $35.81 10/31/202366,400 shares $2.13 million +0.2%N/A664 $32.10 10/15/202366,300 shares $2.13 million No ChangeN/A663 $32.10 9/30/202366,300 shares $2.21 million No ChangeN/A663 $33.34 9/15/202366,300 shares $2.29 million -0.2%N/A663 $34.47 8/31/202366,400 shares $2.56 million -48.4%N/A587.2 $38.51 8/15/2023128,600 shares $4.59 million +0.9%N/A643 $35.70 7/31/2023127,400 shares $4.51 million No ChangeN/A424.7 $35.43 7/15/2023127,400 shares $4.71 million -2.0%N/A212.3 $36.97 6/30/2023130,000 shares $4.68 million -0.1%N/A1300 $36.03A brutally honest economic warning for 2025 (see proof) (Ad)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....Full details here. 6/15/2023130,100 shares $4.94 million +0.9%N/A650.5 $37.96 5/31/2023128,900 shares $4.40 million -2.4%N/A1289 $34.12 5/15/2023132,100 shares $5.44 million +4.1%N/A1321 $41.21 4/30/2023126,900 shares $5.69 million No ChangeN/A1269 $44.87 4/15/2023126,900 shares $5.76 million -0.1%N/A634.5 $45.39 3/31/2023127,000 shares $6.06 million No ChangeN/A1270 $47.70 3/15/2023127,000 shares $8.81 million +33.0%N/A1270 $69.40 2/28/202395,500 shares $6.63 million +140.6%N/A955 $69.40 2/15/202339,700 shares $2.76 million -36.6%N/A397 $69.40 1/31/202362,600 shares $4.29 million +6.8%N/A626 $68.50 1/15/202358,600 shares $4.01 million -10.5%N/A586 $68.50 12/30/202265,500 shares $4.54 million -10.8%N/A655 $69.39 12/15/202273,400 shares $5.09 million -10.2%N/A367 $69.39 11/30/202281,700 shares $5.73 million -0.4%N/A26.4 $70.17 11/15/202282,000 shares $5.47 million +0.4%N/A820 $66.68 10/31/202281,700 shares $4.46 million +55.9%N/A817 $54.60 10/15/202252,400 shares $2.99 million -5.1%N/A524 $57.00 9/30/202255,200 shares $2.91 million +1.5%N/A276 $52.80 9/15/202254,400 shares $3.10 million +56.3%N/A544 $56.96 8/31/202234,800 shares $2.20 million -8.9%N/A348 $63.29 8/15/202238,200 shares $2.42 million +17.5%N/A191 $63.29 7/31/202232,500 shares $2.44 million +0.3%N/A162.5 $75.00 7/15/202232,400 shares $2.47 million -8.7%N/A324 $76.34 6/30/202235,500 shares $2.71 million +1,083.3%N/A355 $76.34 6/15/20223,000 shares $229,020.00 -28.6%N/A30 $76.34 5/31/20224,200 shares $319,200.00 +40.0%N/A42 $76.00 5/15/20223,000 shares $231,000.00 +1,400.0%N/A30 $77.00 4/30/2022200 shares $15,400.00 -86.7%N/A2 $77.00 4/15/20221,500 shares $115,500.00 +200.0%N/A15 $77.00 3/31/2022500 shares $38,500.00 No ChangeN/A5 $77.00 3/15/2022500 shares $30,230.00 No ChangeN/A5 $60.46 2/28/2022500 shares $27,735.00 No ChangeN/A1.7 $55.47 2/15/2022500 shares $30,500.00 -28.6%N/A2.5 $61.00 1/31/2022700 shares $43,092.00 No ChangeN/A1.2 $61.56 1/15/2022700 shares $52,066.00 -93.9%N/A3.5 $74.38 12/31/202111,400 shares $712,500.00 -51.9%N/A10.4 $62.50 12/15/202123,700 shares $1.40 million +115.5%N/A79 $59.10 11/30/202111,000 shares $718,080.00 +20.9%N/A22 $65.28 11/15/20219,100 shares $650,195.00 -14.2%N/A7.6 $71.45 10/29/202110,600 shares $827,330.00 +1.0%N/A21.2 $78.05 10/15/202110,500 shares $856,800.00 +707.7%N/A52.5 $81.60 9/30/20211,300 shares $118,235.00 -86.0%N/A13 $90.95 9/15/20219,300 shares $876,246.00 -88.5%N/A46.5 $94.22 8/31/202180,900 shares $7.12 million -28.3%N/A404.5 $88.05 8/13/2021112,900 shares $9.71 million -21.7%N/A1129 $86.00 7/30/2021144,200 shares $12.33 million -17.2%N/A1442 $85.48 7/15/2021174,200 shares $15.27 million -1.3%N/A1742 $87.66 6/30/2021176,400 shares $16.65 million -10.2%N/A882 $94.36 6/15/2021196,500 shares $18.94 million -2.8%N/A491.3 $96.39 5/28/2021202,100 shares $19.80 million No ChangeN/A673.7 $97.96A brutally honest economic warning for 2025 (see proof) (Ad)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....Full details here. 5/14/2021202,100 shares $20.01 million +6.1%N/A673.7 $99.00 4/30/2021190,500 shares $22.67 million +1.4%N/A381 $119.00 4/15/2021187,800 shares $21.17 million +6.0%N/A626 $112.70 3/31/2021177,200 shares $19.92 million +117.2%N/A295.3 $112.40 3/15/202181,600 shares $10.18 million +6.8%N/A74.2 $124.75 2/26/202176,400 shares $10.54 million +3.1%N/A84.9 $138.00 2/12/202174,100 shares $10.60 million -27.1%N/A23.9 $143.00 1/29/2021101,700 shares $12.92 million -24.1%N/A16.4 $127.00 1/15/2021169,100 shares $16.01 million -32.8%N/A140.9 $94.70 12/31/2020149,400 shares $12.95 million -11.7%N/A747 $86.65 12/15/2020169,100 shares $15.22 million -32.8%N/A140.9 $90.00 11/30/2020251,600 shares $28.93 million +17.4%N/A359.4 $115.00 11/15/2020214,400 shares $26.03 million -6.4%N/A428.8 $121.42 10/30/2020229,100 shares $29.18 million +20.8%N/A381.8 $127.35 10/15/2020189,700 shares $29.02 million +0.2%N/A632.3 $153.00 9/30/2020189,300 shares $23.66 million +0.3%N/A1893 $125.00 9/15/2020188,800 shares $23.60 million -2.4%N/A314.7 $125.00 8/31/2020193,400 shares $19.10 million +0.8%N/A967 $98.75 8/14/2020191,800 shares $18.70 million +7.2%N/A191.8 $97.50 7/31/2020178,900 shares $18.65 million -90.6%N/A57.7 $104.25 7/15/20201,894,500 shares $20.93 million +1.5%N/A222.9 $11.05 6/30/20201,867,300 shares $16.34 million +55.7%N/A128.8 $8.75 6/15/20201,199,200 shares $9.17 million +29.1%N/A176.4 $7.65 5/29/2020928,600 shares $5.90 million +11,507.5%N/A580.4 $6.35 5/15/20208,000 shares $45,200.00 -4.8%N/A0.6 $5.65 4/30/20208,400 shares $48,720.00 +6.3%N/A1.6 $5.80 4/15/20207,900 shares $37,525.00 -33.6%N/A2.7 $4.75 3/31/202011,900 shares $58,310.00 -30.4%N/A1.5 $4.90 PHMMF Short Interest - Frequently Asked Questions What is Pharma Mar's current short interest? Short interest is the volume of Pharma Mar shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 32,700 shares of PHMMF short. 0.18% of Pharma Mar's shares are currently sold short. Learn More on Pharma Mar's current short interest. What is a good short interest ratio for Pharma Mar? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHMMF shares currently have a short interest ratio of 327.0. Learn More on Pharma Mar's short interest ratio. What is a good short interest percentage for Pharma Mar? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.18% of Pharma Mar's floating shares are currently sold short. Is Pharma Mar's short interest increasing or decreasing? Pharma Mar saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 32,700 shares, an increase of 43.4% from the previous total of 22,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pharma Mar's short interest compare to its competitors? 0.18% of Pharma Mar's shares are currently sold short. Here is how the short interest of companies in the industry of "private households" compare to Pharma Mar: Mondi plc (0.01%), Fuchs SE (0.00%), Andritz AG (0.00%), Spirax-Sarco Engineering plc (0.09%), Arkema S.A. (0.00%), AGC Inc. (0.00%), Seiko Epson Co. (0.00%), OMRON Co. (0.01%), Avolta AG (0.01%), Kumba Iron Ore Limited (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Pharma Mar stock? Short selling PHMMF is an investing strategy that aims to generate trading profit from Pharma Mar as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharma Mar? A short squeeze for Pharma Mar occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PHMMF, which in turn drives the price of the stock up even further. How often is Pharma Mar's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHMMF, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies MONDY Short Interest Data TKAMY Short Interest Data TYEKF Short Interest Data ARKAY Short Interest Data KIROY Short Interest Data ASGLY Short Interest Data ADRZY Short Interest Data SPXSF Short Interest Data DUFRY Short Interest Data SEKEY Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PHMMF) was last updated on 3/19/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma Mar, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma Mar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
